Active Ingredient(s):Tetrabenazine FDA Approved: * August 15, 2008 Pharm Company: *PRESTWICK PHARMA Category:Genetic Disorders
Tetrabenazine is a drug for the symptomatic treatment of hyperkinetic movement disorders. It is sold under the brand names Nitoman and Xenazine among others. On August 15, 2008, the U.S. Food and Drug Administration approved the use of tetrabenazine to treat chorea associated with Huntington's disease. Although other drugs had been used "off label," tetrabenazine was the first approved treatment for Huntington's disease in the U.S. The compound has been known since the 1950...
* May have multiple approval dates, manufacturers, or labelers.